| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6016734 | European Journal of Paediatric Neurology | 2015 | 6 Pages |
Abstract
Intravenous administration of levetiracetam is safe and effective for treatment of acute repetitive seizures and convulsive status epilepticus in children and adolescents. Failure of treatment may be related to underlying drug resistant epilepsy. Further study of appropriate initial dosage and pharmacokinetic variations in the patients is needed as possible explanation of the unresponsiveness.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Chaiyos Khongkhatithum, Lunliya Thampratankul, Natrujee Wiwattanadittakul, Anannit Visudtibhan,